Lineage Cell Therapeutics Inc. buy DerAlmanach100000
Start price
22.06.25
/
50%
€0.84
Target price
22.06.28
-
Performance (%)
12.50%
End price
24.07.25
€0.95
Summary
This prediction ended on 24.07.25 with a price of €0.95. The BUY prediction by DerAlmanach100000 finished with a performance of 12.50%. DerAlmanach100000 has a follow-up prediction for Lineage Cell Therapeutics Inc. where he still thinks Lineage Cell Therapeutics Inc. is a Buy. DerAlmanach100000 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Lineage Cell Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 2.591% | 2.691% | 6.411% |
| iShares Nasdaq 100 | -0.915% | -7.368% | 20.651% |
| iShares Nikkei 225® | 0.145% | -10.196% | 46.169% |
| iShares S&P 500 | -0.367% | -0.833% | 18.019% |
According to DerAlmanach100000 what are the pros and cons of Lineage Cell Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by DerAlmanach100000 for this prediction
In the thread Trading Lineage Cell Therapeutics Inc.
Current prediction by DerAlmanach100000 for Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.01
17.07.26
17.07.26
-
17.07.29
17.07.29
-4.95%
30.07.26
30.07.26
Could be very worthwhile Investment >20% year
